Differential anti-diabetic efficacy of incretin agonists vs. DPP-4 inhibition in high fat fed mice

被引：0
|
作者：
Lamont, B. J. [1 ]
Drucker, D. J. [1 ]
机构：
[1] Univ Toronto, BBDC, Toronto, ON, Canada
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0658
引用
收藏
页码：399 / 400
页数：2
相关论文
共 50 条
  • [21] Anti-diabetic Effects of Propolis in High Fat Diet Fed-Streptozotocin-induced Type 2 Diabetic Rat
    Tang, Hung-Wei
    Chan, Ching-Hung
    Lin, Yi-Ting
    Huang, Hui-Yu
    FASEB JOURNAL, 2015, 29
  • [22] Association of SGLT2 Inhibitors and DPP-4 Inhibitors vs. GLP-1 Agonists with Incident CKD in US Veterans
    Kalantar-Zadeh, Kamyar
    Rhee, Connie
    Narasaki, Yoko
    You, Amy S.
    Dashputre, Ankur A.
    Sumida, Keiichi
    Thomas, Fridtjof
    Streja, Elani
    Potukuchi, Praveen Kumar
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 697 - 698
  • [23] Anti-Diabetic and Anti-Adipogenic Effect of Harmine in High-Fat-Diet-Induced Diabetes in Mice
    Morsy, Menna H. E.
    Nabil, Zohour I.
    Darwish, Samah T.
    Al-Eisa, Rasha A.
    Mehana, Amir E.
    LIFE-BASEL, 2023, 13 (08):
  • [24] Anti-diabetic effects of emodin involved in the activation of PPARγ on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice
    Xue, Jianfeng
    Ding, Wenjun
    Liu, Yan
    FITOTERAPIA, 2010, 81 (03) : 173 - 177
  • [25] Vildagliptin, an Anti-diabetic Drug of the DPP-4 Inhibitor, Induces Vasodilation via Kv Channel and SERCA Pump Activation in Aortic Smooth Muscle
    Mi Seon Seo
    Hongliang Li
    Jin Ryeol An
    In Duk Jung
    Won-Kyo Jung
    Kwon-Soo Ha
    Eun-Taek Han
    Seok-Ho Hong
    Il-Whan Choi
    Won Sun Park
    Cardiovascular Toxicology, 2019, 19 : 244 - 254
  • [26] Sorghum extract exerts an anti-diabetic effect by improving insulin sensitivity via PPAR-γ in mice fed a high-fat diet
    Park, Ji Heon
    Lee, Sun Hee
    Chung, Ill-Min
    Park, Yongsoon
    NUTRITION RESEARCH AND PRACTICE, 2012, 6 (04) : 322 - 327
  • [27] The Efficacy of Low vs. High FDA-Approved SGLT2 Inhibitor Dose Compared with DPP-4 Inhibitors: A Meta-analysis
    Uhrig, Jarrod
    Mishriky, Basem M.
    Page, Stephanie O.
    Sewell, Kerry
    Powell, James R.
    Patil, Shivajirao P.
    Cummings, Doyle M.
    DIABETES, 2019, 68
  • [28] Vildagliptin, an Anti-diabetic Drug of the DPP-4 Inhibitor, Induces Vasodilation via Kv Channel and SERCA Pump Activation in Aortic Smooth Muscle
    Seo, Mi Seon
    Li, Hongliang
    An, Jin Ryeol
    Jung, In Duk
    Jung, Won-Kyo
    Ha, Kwon-Soo
    Han, Eun-Taek
    Hong, Seok-Ho
    Choi, Il-Whan
    Park, Won Sun
    CARDIOVASCULAR TOXICOLOGY, 2019, 19 (03) : 244 - 254
  • [29] Use of the Japanese health insurance claims database to assess durability of DPP-4 inhibitors in patients with diabetes: comparison with other anti-diabetic drugs
    Yabe, D.
    Kuwata, H.
    Nishikino, R.
    Kaneko, M.
    Ito, C.
    Murotani, K.
    Kurose, T.
    Seino, Y.
    DIABETOLOGIA, 2015, 58 : S389 - S389
  • [30] Anti-diabetic effects of pomegranate extracts in long-term high fructose-fat fed rats
    Zahra Amri
    Mohamed Raâfet Ben Khedher
    Mohamed Sghaier Zaibi
    Wafa Kharroubi
    Mouna Turki
    Fatma Ayadi
    Mohamed Hammami
    Clinical Phytoscience, 6 (1)
12345